经皮经胸导管引流治疗肺脓肿:系统评价与Meta分析
该系统评价与Meta分析纳入26项研究、194例患者,评估影像引导下经皮导管引流(PCD)治疗肺脓肿的治疗成功率、主要并发症与死亡率。汇总治疗成功率为86.5%(95%CI 78.5-91.8%;I²=23%),主要并发症率为8.1%(95%CI 4.1-15.3%;I²=26%),4例患者最终死于未控制的肺脓肿(汇总率1.5%;95%CI 0.2-11.1%;I²=36%)。恶性肿瘤相关脓肿(OR 0.129;95%CI 0.024-0.724;p=.022)和发生主要并发症(OR 0.065;95%CI 0.02-0.193;p<.001)是治疗失败的显著预测因素;导管穿越正常肺实质是主要并发症的唯一显著危险因素(OR 27.69;95%CI 7.196-123.603;p<.001)。
要点
- 影像引导下PCD治疗肺脓肿汇总成功率为86.5%(95%CI 78.5-91.8%;I²=23%)。
- 导管穿越正常肺实质是主要并发症的唯一显著危险因素(OR 27.69;95%CI 7.196-123.603;p<.001)。
- 恶性肿瘤相关脓肿(OR 0.129;95%CI 0.024-0.724;p=.022)和发生主要并发症(OR 0.065;95%CI 0.02-0.193;p<.001)是治疗失败的显著预测因素。
核心结论
- 影像引导下PCD治疗肺脓肿有效,并发症率低;导管穿越正常肺实质是并发症的唯一危险因素,恶性肿瘤相关脓肿和发生主要并发症是治疗失败的预测因素。
研究设计与样本
- 系统评价与Meta分析,检索Embase和OVID-MEDLINE数据库,纳入26项方法学质量可接受的研究(中位评分4;范围3-5),共194例患者。
- 采用随机截距逻辑回归模型汇总结局,并行多变量Firth偏差校正惩罚似然逻辑回归分析以识别预测因素。
- 方法学质量通过选择、暴露与结局确认、随访时长因果性及报告等条目的二分类应答评分总和评估。
关键影像表现/征象
- 原文不涉及具体影像征象描述,未报告肺脓肿的影像表现特征。
诊断标准与关键数值
- PCD治疗肺脓肿的汇总治疗成功率为86.5%(95%CI 78.5-91.8%;I²=23%)。
- 汇总主要并发症率为8.1%(95%CI 4.1-15.3%;I²=26%)。
- 4例患者最终死于未控制的肺脓肿,汇总死亡率为1.5%(95%CI 0.2-11.1%;I²=36%)。
- 恶性肿瘤相关脓肿与治疗失败相关(OR 0.129;95%CI 0.024-0.724;p=.022)。
- 发生主要并发症与治疗失败相关(OR 0.065;95%CI 0.02-0.193;p<.001)。
临床应用与阅片要点
- 原文结论指出影像引导下PCD治疗肺脓肿有效且并发症率低。
- 原文结论指出导管穿越正常肺实质是并发症的唯一危险因素,恶性肿瘤相关脓肿和发生主要并发症是治疗失败的预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the outcomes of patients receiving image-guided percutaneous catheter drainage (PCD) for lung abscesses in terms of treatment success, major complications, and mortality as well as the predictors of those outcomes.
METHODS: Embase and OVID-MEDLINE databases were searched to identify studies on lung abscesses treated with PCD that had extractable outcomes. The outcomes were pooled using a random-intercept logistic regression model. Multivariate Firth's bias-reduced penalised-likelihood logistic regression analyses were performed to identify predictors of treatment success and complications. Methodological quality was assessed by summing scores of binary responses to items regarding selection, ascertainment of exposure and outcome, causality of follow-up duration, and reporting.
RESULTS: From 26 studies with acceptable methodological quality (median score, 4; range, 3-5), 194 patients were included. The pooled rates of treatment success and major complications were 86.5% (95% confidence interval [CI], 78.5-91.8%; I2 = 23%) and 8.1% (95% CI, 4.1-15.3%; I2 = 26%), respectively. Four patients eventually died from uncontrolled lung abscesses (pooled rate, 1.5%; 95% CI, 0.2-11.1%; I2 = 36%). Malignancy-related abscess (odds ratio [OR], 0.129; 95% CI, 0.024-0.724; p = .022) and the occurrence of a major complication (OR, 0.065; 95% CI, 0.02-0.193; p < .001) were significant predictors of treatment failure. Traversing normal lung parenchyma was the only significant risk factor for major complications (OR, 27.69; 95% CI, 7.196-123.603; p < .001).
CONCLUSION: PCD under imaging guidance was effective for lung abscess treatment, with a low complication rate. Traversal of normal lung parenchyma was the sole risk factor for complications, and malignancy-related abscesses and the occurrence of major complications were predictors of treatment failure.
KEY POINTS: • The pooled treatment success rate of PCD for lung abscess was reasonably high (86.5%); malignancy-related abscesses and the occurrence of a major complication were predictors of treatment failure. • The pooled rate of percutaneous transthoracic catheter drainage-related major complications was 8.1% and traversing normal lung parenchyma by the catheter was the only risk factor. • The pooled mortality rate from uncontrolled lung abscesses with percutaneous transthoracic catheter drainage was low.
引用
- Lee JH, Hong H, Tamburrini M, et al. Percutaneous transthoracic catheter drainage for lung abscess: a systematic review and meta-analysis. Eur Radiol. 2021. PMID: 34327579. doi:10.1007/s00330-021-08149-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。